BROWSE

AJOU Open Repository

Browsing by Ajou Author

researcher image
김, 순선(Kim, Soon Sun) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Gastroenterology]

Author IDs

ORCID
-
ISNI
0000000467833509
WOS
-
SCOPUS
-
Research areas
Co-Researcher

Showing results 1 to 50 of 136

This table browses all dspace content
Pub YearTitleAJOU Author(s)
2025Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea김순선, 한지은
2025Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea김순선
2025Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria김순선, 한지은
2025Role and Activities of the Ethics and Legislation Committee of the Korean Society of Gastroenterology: Introduction to Medical Appraisal and the Medical Dispute Casebook김순선
2025Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study김순선
2025A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma김순선, 은정우, 정재연, 한지은
2025Impact of Antihypertensive and Lipid-Lowering Agents on Hepatocellular Carcinoma Risk in Patients with Fatty Liver Disease and Diabetes김순선, 정재연, 조효정
2025Outcomes of Endoscopic Papillectomy After an Insulated Plastic Pancreatic Stent Placement: A Retrospective Cohort Study김순선, 양민재, 유병무, 최창영, 황재철
2025GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma김순선, 은정우, 임수빈, 정재연, 조효정, 한지은
2025CTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications김순선, 은정우, 정재연, 한지은
2025Clinical Course and Prognosis of Long-Term Survivors of Hepatocellular Carcinoma김순선
2025Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort”김순선, 한지은
2025KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025김순선
2025Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial김순선, 정재연
2025The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on “The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study”김순선, 정재연
2024Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133김순선, 은정우, 임수빈, 정재연, 조효정, 한지은
2024Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma김순선, 은정우, 임수빈, 정재연, 조효정
2024SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea김순선, 정재연, 조효정
2024The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은
2024Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area김순선
2023Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea김순선
2023Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma김순선, 노충균, 양민재, 이길호, 임선교, 정재연, 조효정, 한지은
2023Drug Induced Liver Injury Prediction with Injective Molecular Transformer김순선, 정재연, 조효정, 한지은
2023Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma김순선, 은정우, 정재연, 조효정
2023Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study김순선, 한지은
2023Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis김순선
2023Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma김순선, 은정우, 정재연, 조효정, 한지은
2023Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes김순선, 정재연, 조효정
2023Consensus Definition of Blood Samples from the Subcategorized Normal Controls in the Korea Biobank Network김순선, 정재연, 한지은
2023Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정
2023Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma김봉완, 김순선, 은정우, 정재연, 조효정, 한지은
2023Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection김순선
2023Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly김순선
2022Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment김순선, 박범희, 정재연, 조효정, 한지은
2022295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma김순선, 은정우, 정재연, 조효정, 한지은
2022258 (PB038) - SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma김순선, 은정우, 정재연, 조효정, 한지은
2022Forms of cholangitis to be considered after SARS-CoV-2 infection김순선
2022Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations김순선, 정재연
2022Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미
2022Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma김순선, 은정우, 정재연, 조효정
2022Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma강호철, 김순선, 은정우, 정재연, 조효정
2022Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus김순선, 박범희, 정재연, 조효정, 한지은
2021Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report김순선, 정재연, 조효정, 한지은
2021Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline김순선
2021Effects of high-fidelity simulation education on medical students' anxiety and confidence김미란, 김순선, 박지은, 유지혜, 이장훈, 장혜진, 정우영, 정윤정
2021Assessment of medical students’ clinical performance using high-fidelity simulation: comparison of peer and instructor assessment김미란, 김순선, 노충균, 송미령, 양민재, 유지혜, 이길호, 이미진, 이장훈, 정윤정, 조효정
2021Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers김순선, 은정우, 정재연, 조효정
2021Prognostic value of alpha-fetoprotein in patients who achieve a complete response to transarterial chemoembolization for hepatocellular carcinoma김순선, 정재연, 조효정
2021Independent risk factors for hepatocellular carcinoma recurrence after direct-acting antiviral therapy in patients with chronic hepatitis C김순선, 박범희, 정재연, 조효정
2021HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples김순선, 은정우, 정재연, 조효정
1 2 3
  • License
    sherpa_romeo
    sherpa_juliet

OAK

Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312
Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved.
AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Guide 아주대학교 의학문헌정보센터